Phage-phagocyte interactions and their implications for phage application as therapeutics

Viruses

Volumn 9, Issue 6, 2017, Pages

  Jończyk Matysiak, Ewa ^a   Weber Dąbrowska, Beata ^a   Owczarek, Barbara ^a   Międzybrodzki, Ryszard ^a,b   Łusiak Szelchowska, Marzanna ^a   Łodej, Norbert ^a   Górski, Andrzej ^a,b  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Dendritic cells; Granulocytes; Intracellular killing of bacteria; Monocytes; Phages; Phagocytes; Phagocytosis

Indexed keywords

ANTIGEN; C REACTIVE PROTEIN; CAPSID PROTEIN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHYTOHEMAGGLUTININ; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR;

APOPTOSIS; BACTERICIDAL ACTIVITY; BACTERIOPHAGE; BACTERIUM ADHERENCE; CHEMOTAXIS; CYTOTOXICITY; DEGRANULATION; DENDRITIC CELL; ENDOCYTOSIS; ENTEROBACTERIA PHAGE T4; ERYTHROCYTE SEDIMENTATION RATE; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INFLAMMATION; INNATE IMMUNITY; INTRACELLULAR KILLING; MOLECULAR INTERACTION; MONOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGE THERAPY; PHAGOCYTE; PHAGOCYTOSIS; PSEUDOMONAS AERUGINOSA; RESPIRATORY BURST; REVIEW; STAPHYLOCOCCUS AUREUS; VIRUS ENTRY; VIRUS INACTIVATION; HUMAN; IMMUNOLOGY; PHYSIOLOGY; VIROLOGY;

BACTERIOPHAGES; DENDRITIC CELLS; HUMANS; IMMUNITY, INNATE; MONOCYTES; PHAGE THERAPY; PHAGOCYTES; PHAGOCYTOSIS;

EID: 85021080588     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v9060150     Document Type: Review

References (89)

1. Hazenbos, W.L.W.; Brown, E.J. Phagocytosis: receptors and biology. In Phagocytosis of Bacteria and Bacterial Pathogenicity; Advances in Molecular and Cellular Microbiology, (No. 12); Ernst, J.D., Stendahl, O., Eds.; Cambridge University Press: Cambridge, UK, 2006; ISBN-13 9780511242977.
2. Metchnikoff, E. On the present state of the question of immunity in infectious diseases. In Proceedings of The Nobel Lecture, Stockholm, December 11 December 1908; reprinted in Scand. J. Immunol. 1989, 30, 383–398.
3. Hampton, M.B.; Kettle, A.J.; Winterbourn, C. Inside the neutrophil phagosome: Oxidants, myeloperoxidase, and bacterial killing. Blood 1998, 92, 3007–3017.
4. Labro, M.T. Interference of antibacterial agents with phagocyte functions: Immunomodulation or “immune-fairy tales”? Clin. Microbiol. Rev. 2000, 13, 615–650.
5. Peripheral Blood: Reference Ranges. Adapted from University of Washington Medical Center. Prepared by Patients Against Lymphoma. Available online: http://www.lymphomation.org/peripheral-blood-ref.pdf (accessed on 20 May 2017)
6. Kobayashi, S.D.; Voyich, J.M.; Burlak, C.; DeLeo, F. Neutrophils in the innate immune response. Arch. Immunol. Ther. Exp. 2005, 53, 505–517.
7. Andreesen, R.; Kreutz, M. Differentiation of human monocytes in vitro: A model of macrophage ontogeny. In Cell Culture in Pharmaceutical Research; Ernst Schering Research Foundation Workshop; Springer: Berlin/Heidelberg, Germany, 1994; Volume 11, pp. 9–27.
8. Murray, P.R.; Rosenthal, K.S.; Pfaller, M.A. Mikrobiologia; Przondo-Mordarska, A., Martirosian, G., Szkaradkiewicz, A., Eds.; Elsevier Urban & Partner: Wrocław, Poland, 2011.
9. Johansson, A.A.J.; Jesaitis, H.; Lundquist, K.E.; Magnusson, C.; Sjolin, A.; Karlsson, A.; Dahlgren, C. Different subcellular localization of cytochrome b and the dormant NADPH-oxidase in neutrophils and macrophages: Effect of the production of reactive oxygen species during phagocytosis. Cell. Immunol. 1995, 161, 61–71.
10. Liao, H.F.; Yang, Y.C.; Chen, Y.Y.; Hsu, M.L.; Shieh, H.R.; Chen, Y.J. Macrophages derived from bone marrow modulate differentiation of myeloid dendritic cells. Cell Mol. Life Sci. 2007, 64, 104–111.
11. Underhill, D.M.; Goodridge, H.S. Information processing during phagocytosis. Immunology 2012, 12, 492–502.
12. Hendrix, R.W.; Smith, M.C.M.; Burns, R.N.; Ford, M.E.; Hatfull, G.F. Evolutionary relationships among diverse bacteriophages and prophages: All the world’s a phage. Proc. Natl. Acad. Sci. USA 1999, 96, 2192–2197.
13. Hendrix, R.W. Bacteriophages: Evolution of the majority. Theor. Pop. Biol. 2002, 61, 471–480.
14. Abedon, S.T.; Thomas-Abedon, C.; Thomas, A.; Mazure, H. Bacteriophage prehistory: Is or is not Hankin, 1896, a phage reference? Bacteriophage 2011, 1, 174–178.
15. Reyes, A.; Semenkovich, N.P.; Whiteson, K.; Rohwer, F.; Gordon, J.I. Going viral: Next-generation sequencing applied to phage populations in the human gut. Nat. Rev. Microbiol. 2012, 10, 607–617.
16. Międzybrodzki, R.; Borysowski, J.; Weber-Dąbrowska, B.; Fortuna, W.; Letkiewicz, S.; Szufnarowski, K.; Pawełczyk, Z.; Rogóż, P.; Kłak, M.; Wojtasik, E. et al. Clinical aspects of phage therapy. Adv. Virus Res. 2012, 83, 73–121.
17. Dąbrowska, K.; Opolski, A.; Wietrzyk, J.; Świtala-Jeleń, K.; Boratyński, J.; Nasulewicz, A.; Lipińska, L., Chybicka, A.; Kujawa, M.; Zabel, M. et al. Antitumor activity of bacteriophages in murine experimental cancer models caused possibly by inhibition of beta3 integrin signaling pathway. Acta Virol. 2004, 48, 241–248.
18. NIAID’s Antibacterial Resistance Program: Current Status and Future Directions (2014). Available online: http://www.niaid.nih.gov/topics/antimicrobialresistance/documents/arstrategicplan2014.pdf (accessed on 23 September 2015).
19. Jassim, A.A.A.; Limoges, R.G. Natural solution to antibiotic resistance: Bacteriophages “The Living Drugs”. World J. Microbiol. Biotechnol. 2014, 30, 2153–2170.
20. Górski, A.; Międzybrodzki, R.; Borysowski, J.; Dąbrowska, K.; Wierzbicki, P.; Ohams, M.; Korczak-Kowalska, G.; Olszowska, N.; Łusiak-Szelachowska, M.; Kłak, M. et al. Phage as a modulator of immune responses: Practical implications for phage therapy. Adv. Virus Res. 2012, 83, 41–71.
21. Kurzepa, A.; Dabrowska, K.; Skaradziński, G.; Górski, A. Bacteriophage interactions with phagocytes and their potential significance in experimental therapy. Clin. Exp. Med. 2009, 9, 93–100.
22. Aronow, R.; Danon, D.; Shahar, A.; Aronson, M. Electron microscopy of in vitro endocytosis of T2 phage by cells from rabbit peritoneal exudate. J. Exp. Med. 1964, 120, 943–954.
23. Wenger, S.L.; Turner, J.H.; Petricciani, J.C. The cytogenetic, proliferative and viability effects of four bacteriophages on human lymphocytes. In Vitro 1978, 14, 543–549.
24. Ivanenkov, V.; Felici, F.; Menon, A.G. Uptake and intracellular fate of phage display vectors in mammalian cells. Biochim. Biophys. 1999, 1448, 450–462.
25. Barfoot, R.; Denham, S.; Gyure, L.A.; Hall, J.G.; Hobbs, S.M.; Jackson, L.E.; Robertson, D. Some properties of dendritic macrophages from peripheral lymph. Immunology 1989, 68, 233–239.
26. Kaźmierczak, Z.; Piotrowicz, A.; Owczarek, B.; Hodyra, K.; Miernikiewicz, P.; Lecion, D.; Harhala, M.; Górski, A.; Dąbrowska, K. Molecular imaging of T4 phage in mammalian tissues and cells. Bacteriophage 2014, 4, e28364.
27. Hodyra-Stefaniak, K.; Miernikiewicz, P.; Drapała, J.; Drab, M.; Jończyk-Matysiak, E.; Lecion, D.; Kaźmierczak, Z.; Beta, W.; Majewska, J.; Bubak, B. et al. Mammalian host-versus-phage immune response determines phage fate in vivo. Sci. Rep. 2015, 5, 14802.
28. d’Herelle, F. Bacteriophage: Its Role in Immunity; Williams & Wilkins Company: Baltimore, MD, USA, 1922.
29. Nelson, A.R. The effect of bacteriophage upon the phenomena of leukocytosis and phagocytosis. J. Immunol. 1928, 15, 43–64.
30. Młynarczyk, G.; Garliński, P.; Młynarczyk, A.; Zabuska, K.; Sawicka-Grzelak, A.; Machowska, G.; Osowiecki, H.; Roszkowski, W. Bacteriophage conversion as a factor modifying the intensity of phagocytosis of Staphylococcus aureus by human leukocytes. Medycyna Doświadczalna Mikrobiologia 1989, 41, 86–91.
31. Secor, P.R.; Michaels, L.A.; Smigiel, K.S.; Rohani, M.G.; Jennings, L.K.; Hisert, K.B.; Arrigoni, A.; Braun, K.R.; Birkland, T.P.; Lai, Y. et al. Filamentous bacteriophage produced by Pseudomonas aeruginosa alters the inflammatory response and promotes noninvasive infection in vivo. Infect. Immunol. 2017, 85, e00648–e00616.
32. Smith G.H. Bacteriophage and phagocytosis. I Effect on resistant and dead bacteria. J. Immunol. 1928, 15, 125–140.
33. Weber-Dąbrowska, B.; Zimecki, M.; Mulczyk, M.; Górski, A. Effect of phage therapy on the turnover and function of peripheral neutrophils. FEMS Immunol. Med. Microb. 2002, 34, 135–138.
34. Jończyk-Matysiak, E.; Łusiak-Szelachowska, M.; Kłak, M.; Bubak, B.; Międzybrodzki, R.; Weber-Dąbrowska, B.; Żaczek, M.; Fortuna, W.; Rogóż, P.; Letkiewicz, S. et al. The effect of bacteriophage preparations on intracellular killing of bacteria by phagocytes. J. Immunol. Res. 2015, 2015, 482863.
35. Kurzępa-Skaradzińska, A.; Łusiak-Szelachowska, M.; Skaradziński, G.; Jończyk-Matysiak, E.; Weber-Dąbrowska, B.; Żaczek, M.; Maj, T.; Sławek, A.; Rymowicz, W.; Kłak, M. et al. Influence of bacteriophage preparations on intracellular killing of bacteria by human phagocytes in vitro. Viral Immunol. 2013, 26, 150–162.
36. Chhibber, S.; Kaur, T.; Kaur, S. Co-therapy using lytic bacteriophage and linezolid: Effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections. PLoS ONE 2013, 8, e56022
37. Tiwari, B.R.; Kim, S.; Rahman, M.; Kim, J. Antibacterial efficacy of lytic Pseudomonas bacteriophage in normal and neutropenic mice models. J. Microbiol. 2011, 49, 994–999.
38. Briones, E.; Colino, C.I.; Lanao, J.M. Delivery systems to increase the selectivity of antibiotics in phagocytic cells. J. Control Release 2008, 125, 210–227.
39. Broxmeyer, L.; Sosnowska, D.; Miltner, E.; Chacćon, O.; Wagner, D.; McGarvey, J.; Bareltta, R.G.; Bermudez, L. Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: A model for phage therapy of intracellular bacterial pathogens. J. Infect. Dis. 2002, 186, 1155–1160.
40. Capparelli, R.; Parlato, M.; Borriello, G.; Salvatore, P.; Iannelli, D. Experimental phage therapy against Staphylococcus aureus in mice. Antimicrob. Agents Chemiother. 2007, 51, 2765–2773.
41. Kaur, S.; Harjai, K.; Chhibber, S. Bacteriophage-aided intracellular killing of engulfed methicillin-resistant Staphylococcus aureus (MRSA) by murine macrophages. Appl. Microbiol. Biotechnol. 2014, 98, 4653–4661.
42. Baughn, R.; Bonventre, P.F. Phagocytosis and intracellular killing of Staphylococcus aureus by normal mouse peritoneal macrophages. Infect. Immun. 1975, 12, 346–352.
43. Przerwa, A.; Zimecki, M.; Świtała-Jeleń, K.; Dąbrowsk, K.; Krawczyk, E.; Łuczak, M.; Weber-Dąbrowska, B.; Syper, D.; Międzybrodzki, R.; Górski, A. Effects of bacteriophages on free radical production and phagocytic functions. Med. Microbiol. Immunol. 2006, 195, 143–150.
44. Międzybrodzki, R.; Świtala-Jeleń, K.; Fortuna, W.; Weber-Dąbrowska, B.; Przerwa, A.; Łusiak-Szelachowska, M.; Dąbrowska, K.; Kurzępa, A; Boratyński, J.; Syper, D. et al. Bacteriophage preparation inhibition of reactive oxygen species generation by endotoxin-stimulated polymorphonuclear leukocytes. Virus Res. 2008, 131, 233–242.
45. Miernikiewicz, P.; Dąbrowska, K.; Piotrowicz, A.; Owczarek, B.; Wojas-Turek, J.; Kicielińska, J.; Rossowska, J.; Pajtasz-Piasecka, E.; Hodyra, K.; Macegoniuk, K.; et al. Cytokine profiles in mice and in human blood treated with phage proteins. PLoS ONE 2013, 8, e71036.
46. Borysowski, J.; Wierzbicki, P.; Kłosowska, D.; Korczak-Kowalska, G.; Weber-Dąbrowska, B.; Górski, A. The effects of T4 and A3/R phage preparations on whole-blood monocyte and neutrophil respiratory burst. Viral Immunol. 2010, 23, 541–544
47. Borysowski, J.; Międzybrodzki, R.; Wierzbicki, P.; Kłosowska, D.; Korczak-Kowalska G.; Weber-Dąbrowska, B.; Górski, A. A3R phages and Staphylococcus aureus lysate do not induce neutrophil degranulation. Viruses 2017, 9, 36.
48. Górski, A.; Międzybrodzki, R.; Weber-Dąbrowska, B.; Fortuna, W.; Letkiewicz, S.; Rogóż, P.; Jończyk-Matysiak, E.; Dąbrowska, K.; Majewska, J.; Borysowski, J. Phage Therapy: Combating Infections with Potential for Evolving from Merely a Treatment for Complications to Targeting Diseases. Front. Microbiol. 2016, 7, 1515.
49. Bocian, K.; Borysowski, J.; Zarzycki, M.; Pacek, M.; Weber-Dąbrowska, B.; Machcińska, M.; Korczak-Kowalska, G.; Górski, A. The effects of T4 and A3/R bacteriophages on differentiation of human myeloid dendritic cells. Front. Microbiol. 2016, 7, 1267.
50. Bocian, K.; Borysowski, J.; Zarzycki, M.; Wierzbicki, P.; Kłosowska, D.; Weber-Dąbrowska, B.; Korczak-Kowalska, G.; Górski, A. LPS-activated monocytes are unresponsive to T4 phage and T4-generated Escherichia coli lysate. Front. Microbiol. 2016, 7, 1356.
51. Ann, T.W.; Kim, S.J.; Lee, Y.D.; Park, J.H.; Chang, H.I. The immune-enhancing effect of the Cronobacter sakazakii ES2 phage results in the activation of nuclear factor-κB and dendritic cell maturation via the activation of IL-12p40 in the mouse bone marrow. Immunol. Lett. 2014, 157, 1–8.
52. Miernikiewicz, P.; Kłopot, A.; Soluch, R.; Szkuta, P.; Kęska, W.; Hodyra-Stefaniak, K.; Konopka, A.; Nowak, M.; Lecion, D.; Kaźmierczak, Z. et al. T4 phage tail adhesin gp12 counteracts LPS-induced inflammation in vivo. Front. Microbiol. 2016, 7, 1112.
53. Anany, H.; Chen, W.; Pelton, R.; Griffiths, M.W. Biocontrol of Listeria monocytogenes and Escherichia coli O157:H7 in meat by using phages immobilized on modified cellulose membranes. Appl. Environ. Microbiol. 2011, 6379–6387.
54. Dąbrowska, K.; Zembala, M.; Boratyński, J.; Świtała-Jeleń, K.; Wietrzyk, J.; Opolski, A.; Szczaurska, K.; Kujawa, M.; Godlewska, J.; Górski, A. Hoc protein regulates the biological effects of T4 phage in mammals. Arch. Microbiol. 2007, 187, 489–498.
55. Kruger, A.P.; Ritter, R.C.; Smith, P. The electrical charge of bacteriophage. J. Exp. Med. 1929, 50, 739–746.
56. Burnet, F.M.; Mckie, M. The electrical behaviour of bacteriophages. Aust. J. Exp. Biol. Med. Sci. 1930, 7, 199–209.
57. Zemb, O.; Manefield, M.; Thomas, F.; Jacquet, S. Phage adsorption to bacteria in the light of the electrostatics: a case study using E. coli, T2 and flow cytometry. J. Virol. Methods 2013, 189, 283–289.
58. Getts, D.R.; Terry, R.L.; Getts, M.T.; Deffrasnes, C.; Müller, M.; van Vreden, C.; Ashhurst, T.M.; Chami, B.; McCarthy, D.; Wu, H.; et al. Therapeutic inflammatory monocyte modulation using immune-modifying microparticles. Sci. Transl. Med. 2014, 6, 219ra7.
59. Zimecki, M.; Weber-Dąbrowska, B.; Łusiak-Szelachowska, M.; Mulczyk, M.; Boratyński, J.; Poźniak, G.; Syper, D.; Górski, A. Bacteriophages provide regulatory signals in mitogen-induced murine splenocyte proliferation. Cell. Mol. Biol. Lett. 2003, 8, 699–711.
60. Stapels, D.C.A.; Ramyar, K.X.; Bischoff, M.; von Köckritz-Blickwede, M.; Milder, F.J.; Ruyken, M.; Eisenbeis, J.; McWhorter, W.J.; Herrmann, M.; van Kessel, K.P.; et al. Staphylococcus aureus secretes a unique class of neutrophil serine protease inhibitors. Proc. Natl. Acad. Sci. USA 2014, 111, 13187–13192.
61. Międzybrodzki, R.; Fortuna, W.; Weber-Dąbrowska, B.; Górski, A. A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses. Clin. Exp. Med. 2009, 9, 303–312.
62. Jończyk-Matysiak, E.; Kłak, M.; Łusiak-Szelachowska, M.; Bubak, B.; Międzybrodzki, R.; Weber-Dąbrowska, B.; Żaczek, M.; Górski, A. The effect of bacteriophage preparations on bone marrow functions and the level of inflammatory markers in blood of patients treated with phage preparations. In Proceedings of the 21st Biennial Evergreen International Phage Meeting, Evergreen, Washington, DC, USA, 2–8 August 2015.
63. Delves, P.J.; Martin, S.J.; Burton, D.R.; Roitt, I.M. Roitt’s Essential Immunology, Includes Desktop Edition, 12th ed.; Wiley-Blackwell: Hoboken, NJ, USA, 2011; ISBN-13 978-1405196833.
64. Rosen, G.M.; Pou, S.; Ramos, C.L.; Cohen, M.S.; Britigan, B.E. Free radicals and phagocytic cells. FASEB J. 1995, 9, 200–209.
65. Selsted, M.E.; Harwig, S.L. Purification, primary structure, and antimicrobial activities of a guinea pig neutrophil defensin. Infect. Immun. 1987, 55, 2281–2286.
66. Zerial, A.; Skerlavaj, B.; Gennaro, R.; Romeo, D. Inactivation of herpes simplex virus by protein components of bovine neutrophil granules. Antivir. Res. 1987, 7, 341–352.
67. Klempner, M.S.; Dinarello, C.A.; Gallis, J.I. Human leukocytic pyrogen induces release of specific granule contents from human neutrophils. J. Clin. Investig. 1978, 61, 1330–1336.
68. Schwarz, K.B. Oxidative stress during viral infection: A review. Free Radic. Biol Med. 1996 21, 641–649.
69. Suzuki, S.; Kimura, T.; Ikuta, K. Superoxide generation and human cytomegalovirus infection. Nihon Rinsho 1998, 56, 75–78.
70. Peterhans, E. Sendai virus stimulates chemiluminescence in mouse spleen cells. Biochem. Biophys. Res. Commun. 1979, 91, 383–392.
71. Debets-Ossenkopp, Y.; Mills, E.L.; van Dajk, W.C.; Verbrugh, H.A.; Verhoef, J. Effect of influenza virus on phagocytic cells. Eur. J. Clin. Microbiol. 1982, 1, 171–177.
72. Skarman, P.J.; Rahbar, A.; Xie, X.; Söderberg-Nauclér, C. Induction of polymorphonuclear leucocyte response by human cytomegalovirus. Microbes Infect. 2006, 8, 1592–1601.
73. Savard, M.; Bélanger, C.; Tardif, M.; Gourde, P.; Flamand, L.; Gosselin, J. Infection of primary human monocytes by Epstein-Barr virus. J. Virol. 2000, 74, 2612–2619.
74. Gorczyca, W.A.; Mitkiewicz, M.; Siednienko, J.; Kurowska, E.; Piasecki, E.; Weber-Dąbrowska, B.; Górski A. Bacteriophages decrease activity of NFκB induced in human mononuclear cells by human herpesvirus-1. In Proceedings of the 13th International Congress of Immunology, Rio de Janeiro, Brasil, 21–25 August 2007.
75. Khanna, N.; Agnihotri, M.; Mathur, A.; Chaturvedi, U.C. Neutrophil chemotactic factor produced by Japanese encephalitis virus stimulated macrophages. Clin. Exp. Immunol. 1991, 86, 299–303.
76. Jaye, D.L.; Edens, H.A.; Mazzucchelli, L.; Parkos, C.A. Novel G protein-coupled responses in leukocytes elicited by a chemotactic bacteriophage displaying a cell type-selective binding peptide. J. Immunol. 2001, 166, 7250–7259.
77. Van Strijp, J.A.; Miltenburg, L.A.; van der Tol, M.E.; Van Kessel, K.P.; Fluit, A.C.; Verhoef, J. Degradation of herpes simplex virions by human polymorphonuclear leukocytes and monocytes. J. Gen. Virol. 1990, 71, 1205–1209.
78. Merchant, D.J.; Morgan H.R. Inhibition of the phagocytic action of leucocytes by mumps and influenza viruses. Proc. Soc. Exp. Biol. Med. 1950, 74, 651–653.
79. Yamamoto, K.; Suzuki, K.; Suzuki, K.; Mizuno, S. Phagocytosis and ingestion of influenza virus by human polymorphonuclear leucocytes in vitro: Electromicroscopy studies. J. Med. Microbiol. 1989, 28, 191–198.
80. Pang, G.; Clancy, R.; Gong, M.; Ortega, M.; Ren, Z. G.; Reeves, G. Influenza virus inhibits lysozyme secretion by sputum neutrophils in subjects with chronic bronchial sepsis. Am. J. Respir. Crit. Care Med. 2000, 161, 718–722.
81. Warr, G.A.; Jakab, G.J.; Chan, T.W.; Tsan, M.F. Effects of viral pneumonia on lung macrophage lysosomal enzymes. Infect. Immun. 1979, 24, 577–579.
82. Kańtoch, M.; Dubowska-Inglot, A. Inhibition of phagocytic activity of leukocytes by Coxsackie virus. I: The influence of the viral concentration and temperature on the inhibition of phagocytosis. Pathol. Microbiol. 1960, 23, 83–94.
83. Chaturvedi, U.C.; Mathur, A.; Tandon, P.; Natu, S.M.; Ray-Vanishi, S.; Tandon, H.O. Variable effect on peripheral blood leucocytes during JE virus infection of man. Clin. Exp. Immunol. 1979, 38, 492–498.
84. Faden, H.; Humbert, J.; Lee, J.; Sutyla, P.; Ogra, P.L. The in vitro effects of Newcastle disease virus on the metabolic and antibacterial functions of human neutrophils. Blood 1981, 58, 221–227.
85. Ferrini, U.; Mileo, M.M.; Nista, A.; Mattei, E.; Orofino, A. Polymorphonuclear leucocyte stimulation measured by phage inactivation. Int. Arch. Allergy Appl. Immunol. 1989, 90, 207–212.
86. Jaovisidha, P.; Peeples, M.E.; Brees, A.A.; Carpenter, L.R.; Moy, J.N. Respiratory syncytial virus stimulates neutrophil degranulation and chemokine release. J. Immunol. 1999, 163, 2816–2820.
87. Michailidis, C.; Giannopoulos, G.; Vigklis, V.; Armenis, K.; Tsakris, A.; Gargalianos P. Impaired phagocytosis among patients infected by the human immunodeficiency virus: Implication for a role of highly active anti-retroviral therapy. Clin. Exp. Immunol. 2012, 167, 499–504.
88. Arias, C.F.; Isa, P.; Guerrero, C.A.; Méndez, E.; Zárate, S.; López, T.; Espinosa, R.; Romero, P.; López, S. Molecular biology of rotavirus cell entry. Arch. Med. Res. 2002, 33, 356–361.
89. Pitrak, D.; Tsai, H.; Mullane, K.; Sutton, S.; Stevens, P. Accelerated neutrophil apoptosis in the acquired immunodeficiency syndrome. J. Clin. Investig. 1996, 98, 2714–2719.